ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

Society Recognizes Community Oncologists (8-page issue).

June 6, 2003

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Abbott To Supply Quest With Immunoassay Tests.

September 29, 2000

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010